PAR 11.1% 30.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM REPORTS CONSISTENT OA PAIN REDUCTION, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 189 Posts.
    lightbulb Created with Sketch. 20
    Apologies - got it:

    "In this pilot study, 4 weekly injections of NaPPS were associated with significantly improved duration of joint stiffness and pain at rest compared with controls for 20 weeks after the cessation of treatment, and significantly improved pain on walking and overall function for 8 weeks after the cessation of treatment in these patients with OA of the knee."
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.030(11.1%)
Mkt cap ! $82.30M
Open High Low Value Volume
27.5¢ 30.0¢ 27.5¢ $401.0K 1.398M

Buyers (Bids)

No. Vol. Price($)
3 224067 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 109891 3
View Market Depth
Last trade - 12.38pm 22/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.